{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T21:27:41Z","timestamp":1771104461518,"version":"3.50.1"},"reference-count":134,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.thromres.2006.11.012","type":"journal-article","created":{"date-parts":[[2007,1,18]],"date-time":"2007-01-18T07:19:11Z","timestamp":1169104751000},"page":"323-336","source":"Crossref","is-referenced-by-count":140,"title":["Measuring antiplatelet drug effects in the laboratory"],"prefix":"10.1016","volume":"120","author":[{"given":"Paul","family":"Harrison","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"A.L.","family":"Frelinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark I.","family":"Furman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan D.","family":"Michelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2006.11.012_bib1","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1136\/jcp.41.12.1322","article-title":"Guidelines on platelet function testing. The British Society for Haematology BCSH Haemostasis and Thrombosis Task Force","volume":"41","year":"1988","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.thromres.2006.11.012_bib2","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1172\/JCI27196","article-title":"Platelets in inflammation and atherogenesis","volume":"115","author":"Gawaz","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.thromres.2006.11.012_bib3","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/nm1102-1227","article-title":"Platelets in atherothrombosis","volume":"8","author":"Ruggeri","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.thromres.2006.11.012_bib4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.blre.2004.05.002","article-title":"Platelet function analysis","volume":"19","author":"Harrison","year":"2005","journal-title":"Blood Rev"},{"key":"10.1016\/j.thromres.2006.11.012_bib5","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1365-2141.2000.02269.x","article-title":"Progress in the assessment of platelet function","volume":"111","author":"Harrison","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2006.11.012_bib6","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1055\/s-0037-1616519","article-title":"A new blood corpuscle: an impossible interview with Giulio Bizzozero","volume":"86","author":"de Guetano","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2006.11.012_bib7","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1001\/jama.1910.04330140029009","article-title":"The relation of blood platelets to hemorrhagic disease. Description of a method for determining the bleeding time and the coagulation time and report of three cases of hemorrhagic disease relieved by blood transfusion","volume":"55","author":"Duke","year":"1910","journal-title":"JAMA"},{"key":"10.1016\/j.thromres.2006.11.012_bib8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1056\/NEJM197207272870401","article-title":"The bleeding time as a screening test for evaluation of platelet function","volume":"287","author":"Harker","year":"1972","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2006.11.012_bib9","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1055\/s-0038-1654776","article-title":"The Duke and Ivy Methods for determination of the bleeding time","volume":"10","author":"Nilsson","year":"1963","journal-title":"Thromb Diath Haemorrh"},{"key":"10.1016\/j.thromres.2006.11.012_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2007-1002658","article-title":"A critical reappraisal of the bleeding time","volume":"16","author":"Rodgers","year":"1990","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.thromres.2006.11.012_bib11","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1182\/blood.V77.12.2547.2547","article-title":"The bleeding time does not predict surgical bleeding","volume":"77","author":"Lind","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2006.11.012_bib12","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1001\/archsurg.133.2.134","article-title":"The preoperative bleeding time test lacks clinical benefit: College of American Pathologists' and American Society of Clinical Pathologists' position article","volume":"133","author":"Peterson","year":"1998","journal-title":"Arch Surg"},{"key":"10.1016\/j.thromres.2006.11.012_bib13","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/194927b0","article-title":"Aggregation of blood platelets by adenosine diphosphate and its reversal","volume":"194","author":"Born","year":"1962","journal-title":"Nature"},{"key":"10.1016\/j.thromres.2006.11.012_bib14","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/jcp.15.5.452","article-title":"Platelet aggregation. II. Some results from a new method of study","volume":"15","author":"O'Brien","year":"1962","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.thromres.2006.11.012_bib15","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1309\/Y9EC63RW3XG1V313","article-title":"Platelet aggregation testing in platelet-rich plasma: description of procedures with the aim to develop standards in the field","volume":"123","author":"Zhou","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.thromres.2006.11.012_bib16","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1160\/TH04-10-0670","article-title":"Variability in clinical laboratory practice in testing for disorders of platelet function: results of two surveys of the North American Specialized Coagulation Laboratory Association","volume":"93","author":"Moffat","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2006.11.012_bib17","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0160-5402(80)90024-8","article-title":"The electronic aggregometer: a novel device for assessing platelet behavior in blood","volume":"3","author":"Cardinal","year":"1980","journal-title":"J Pharmacol Methods"},{"key":"10.1016\/j.thromres.2006.11.012_bib18","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/01.CIR.99.5.620","article-title":"Rapid platelet-function assay: an automated and quantitative cartridge-based method","volume":"99","author":"Smith","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2006.11.012_bib19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1023\/A:1008931126871","article-title":"Efficacy of abciximab induced platelet blockade using a rapid point of care assay","volume":"7","author":"Kereiakes","year":"1999","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.thromres.2006.11.012_bib20","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1161\/01.CIR.95.4.860","article-title":"Rapid and simple platelet function assay to assess glycoprotein IIb\/IIIa receptor blockade","volume":"95","author":"Coller","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2006.11.012_bib21","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1055\/s-0038-1657292","article-title":"Platelet aggregation in whole blood determined using the Ultra-Flo 100 Platelet Counter","volume":"48","author":"Fox","year":"1982","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2006.11.012_bib22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0049-3848(86)90297-5","article-title":"Inhibition of platelet aggregation in whole blood by dipyridamole and aspirin","volume":"42","author":"Heptinstall","year":"1986","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2006.11.012_bib23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/09537100500063889","article-title":"Leukocyte count and leukocyte ecto-nucleotidase are major determinants of the effects of adenosine triphosphate and adenosine diphosphate on platelet aggregation in human blood","volume":"16","author":"Glenn","year":"2005","journal-title":"Platelets"},{"key":"10.1016\/j.thromres.2006.11.012_bib24","first-page":"171","article-title":"Whole blood platelet function assay on the ICHOR point-of-care hematology analyzer","volume":"30","author":"Carville","year":"1998","journal-title":"J Extra Corpor Technol"},{"key":"10.1016\/j.thromres.2006.11.012_bib25","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.lab.2005.03.010","article-title":"Comparison of modified Thrombelastograph and Plateletworks whole blood assays to optical platelet aggregation for monitoring reversal of clopidogrel inhibition in elective surgery patients","volume":"145","author":"Craft","year":"2005","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.thromres.2006.11.012_bib26","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11239-005-0341-x","article-title":"The use of the point of care Helena ICHOR\/Plateletworks and the Accumetrics Ultegra RPFA for assessment of platelet function with GPIIb\u2013IIIa antagonists","volume":"18","author":"White","year":"2004","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.thromres.2006.11.012_bib27","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1053\/j.jvca.2004.01.015","article-title":"A comparison of Plateletworks and platelet aggregometry for the assessment of aspirin-related platelet dysfunction in cardiac surgical patients","volume":"18","author":"Lennon","year":"2004","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.thromres.2006.11.012_bib28","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/09537100400028800","article-title":"A new point-of-care method for monitoring anti-platelet therapy: application of the cone and plate(let) analyzer","volume":"16","author":"Spectre","year":"2005","journal-title":"Platelets"},{"key":"10.1016\/j.thromres.2006.11.012_bib29","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1365-2141.1998.00690.x","article-title":"Cone and platelet analyser (CPA): a new test for the prediction of bleeding among thrombocytopenic patients","volume":"101","author":"Kenet","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2006.11.012_bib30","doi-asserted-by":"crossref","first-page":"S187","DOI":"10.1016\/S0002-8703(98)70248-0","article-title":"Cone and plate(let) analyzer: monitoring glycoprotein IIb\/IIIa antagonists and von Willebrand disease replacement therapy by testing platelet deposition under flow conditions","volume":"135","author":"Varon","year":"1998","journal-title":"Am Heart J"},{"key":"10.1016\/j.thromres.2006.11.012_bib31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2005.05511.x","article-title":"The role of PFA-100 testing in the investigation and management of haemostatic defects in children and adults","volume":"130","author":"Harrison","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2006.11.012_bib32","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1067\/mlc.2001.117406","article-title":"Platelet function analyzer (PFA-100): a tool to quantify congenital or acquired platelet dysfunction","volume":"138","author":"Jilma","year":"2001","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.thromres.2006.11.012_bib33","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/107602969600200404","article-title":"Characterization of an in vitro platelet function analyzer \u2014 PFA-100","volume":"2","author":"Kundu","year":"1996","journal-title":"Clin Appl Thromb Hemost"},{"issue":"Suppl 2","key":"10.1016\/j.thromres.2006.11.012_bib34","first-page":"106","article-title":"Description of an in vitro platelet function analyzer \u2014 PFA-100","volume":"21","author":"Kundu","year":"1995","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.thromres.2006.11.012_bib35","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1055\/s-0038-1642647","article-title":"Platelet-vessel wall interaction: from the bedside to molecules","volume":"74","author":"Caen","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2006.11.012_bib36","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1477-9560-3-16","article-title":"Towards a standardization of thrombin generation assessment: the influence of tissue factor, platelets and phospholipids concentration on the normal values of Thrombogram\u2013Thrombinoscope assay","volume":"3","author":"Gerotziafas","year":"2005","journal-title":"Thromb J"},{"key":"10.1016\/j.thromres.2006.11.012_bib37","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1055\/s-0037-1613258","article-title":"The thrombogram in rare inherited coagulation disorders: its relation to clinical bleeding","volume":"88","author":"Al","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2006.11.012_bib38","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1055\/s-0038-1642666","article-title":"Thrombin generation in plasma: its assessment via the endogenous thrombin potential","volume":"74","author":"Hemker","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2006.11.012_bib39","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0049-3848(99)00034-1","article-title":"Inhibition of platelet aggregation by abciximab but not by aspirin can be detected by a new point-of-care test, the hemostatus","volume":"95","author":"Coiffic","year":"1999","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2006.11.012_bib40","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0140-6736(98)12494-7","article-title":"Use of point-of-care test in identification of patients who can benefit from desmopressin during cardiac surgery: a randomised controlled trial","volume":"354","author":"Despotis","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2006.11.012_bib41","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1097\/00000542-199612000-00012","article-title":"Evaluation of a new point-of-care test that measures PAF-mediated acceleration of coagulation in cardiac surgical patients","volume":"85","author":"Despotis","year":"1996","journal-title":"Anesthesiology"},{"key":"10.1016\/j.thromres.2006.11.012_bib42","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2257.2005.00681.x","article-title":"Thromboelastography\/thromboelastometry","volume":"27","author":"Luddington","year":"2005","journal-title":"Clin Lab Haematol"},{"key":"10.1016\/j.thromres.2006.11.012_bib43","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00001721-200107000-00001","article-title":"Thromboelastography","volume":"12","author":"Salooja","year":"2001","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.thromres.2006.11.012_bib44","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF02044776","article-title":"Thrombelastography, a method for physical analysis of blood coagulation","volume":"117","author":"Hartert","year":"1951","journal-title":"Z Gesamte Exp Med"},{"key":"10.1016\/j.thromres.2006.11.012_bib45","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/01.mbc.0000169225.31173.19","article-title":"Multi-centre investigation on reference ranges for ROTEM thromboelastometry","volume":"16","author":"Lang","year":"2005","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.thromres.2006.11.012_bib46","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.jacc.2005.05.090","article-title":"Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation","volume":"46","author":"Tantry","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.thromres.2006.11.012_bib47","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/107602960300900208","article-title":"Value of thromboelastography in the assessment of platelet function","volume":"9","author":"Bowbrick","year":"2003","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.thromres.2006.11.012_bib48","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00000441-199107000-00004","article-title":"Measurement of platelet-mediated force development during plasma clot formation","volume":"302","author":"Carr","year":"1991","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.thromres.2006.11.012_bib49","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1046\/j.1538-7836.2003.00337.x","article-title":"Onset of force development as a marker of thrombin generation in whole blood: the thrombin generation time (TGT)","volume":"1","author":"Carr","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2006.11.012_bib50","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1385\/CBB:38:1:55","article-title":"Development of platelet contractile force as a research and clinical measure of platelet function","volume":"38","author":"Carr","year":"2003","journal-title":"Cell Biochem Biophys"},{"key":"10.1016\/j.thromres.2006.11.012_bib51","unstructured":"Carr Jr ME. Measurement of platelet force: the Hemodyne hemostasis analyzer. Clin.Lab Manage.Rev. 1995;9:312-8, 320."},{"key":"10.1016\/j.thromres.2006.11.012_bib52","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/00062752-199909000-00012","article-title":"Laboratory markers of platelet activation and their clinical significance","volume":"6","author":"Michelson","year":"1999","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.thromres.2006.11.012_bib53","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1055\/s-0037-1615088","article-title":"European Working Group on Clinical Cell Analysis: consensus protocol for the flow cytometric characterisation of platelet function","volume":"79","author":"Schmitz","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2006.11.012_bib54","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.1182\/blood.V87.12.4925.bloodjournal87124925","article-title":"Flow cytometry: a clinical test of platelet function","volume":"87","author":"Michelson","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2006.11.012_bib55","doi-asserted-by":"crossref","first-page":"e489","DOI":"10.1161\/01.CIR.0000147228.29325.F9","article-title":"Platelet function testing in cardiovascular diseases","volume":"110","author":"Michelson","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2006.11.012_bib56","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1161\/01.ATV.0000145980.39477.a9","article-title":"Aspirin and clopidogrel: efficacy, safety, and the issue of drug resistance","volume":"24","author":"Cattaneo","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.thromres.2006.11.012_bib57","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1111\/j.1538-7836.2005.01351.x","article-title":"Aspirin resistance: position paper of the Working Group on Aspirin Resistance","volume":"3","author":"Michelson","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2006.11.012_bib58","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jacc.2005.08.058","article-title":"Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance","volume":"47","author":"Lev","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.thromres.2006.11.012_bib59","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1111\/j.1538-7836.2005.01372.x","article-title":"Aspirin resistance","volume":"3","author":"Szczeklik","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2006.11.012_bib60","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1172\/JCI108132","article-title":"The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein","volume":"56","author":"Roth","year":"1975","journal-title":"J Clin Invest"},{"key":"10.1016\/j.thromres.2006.11.012_bib61","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.thromres.2006.11.012_bib62","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1111\/j.1538-7836.2005.01380.x","article-title":"Determinants of the interindividual variability in response to antiplatelet drugs","volume":"3","author":"Rocca","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2006.11.012_bib63","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.amjcard.2004.12.038","article-title":"Compliance as a critical consideration in patients who appear to be resistant to aspirin after healing of myocardial infarction","volume":"95","author":"Schwartz","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.thromres.2006.11.012_bib64","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1161\/CIRCULATIONAHA.105.596627","article-title":"Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway. A 700-patient study of aspirin resistance","volume":"113","author":"Frelinger","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2006.11.012_bib65","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/09537100120104890","article-title":"Towards a definition of aspirin resistance: a typological approach","volume":"13","author":"Weber","year":"2002","journal-title":"Platelets"},{"key":"10.1016\/j.thromres.2006.11.012_bib66","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1055\/s-0037-1613805","article-title":"Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100","volume":"83","author":"Homoncik","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2006.11.012_bib67","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1055\/s-2005-916675","article-title":"Monitoring acetylsalicylic acid effects with the platelet function analyzer PFA-100","volume":"31","author":"Feuring","year":"2005","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.thromres.2006.11.012_bib68","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0049-3848(02)00405-X","article-title":"Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease","volume":"108","author":"Andersen","year":"2002","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2006.11.012_bib69","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/69537100412351272550","article-title":"The PFA-100 detects sub-optimal antiplatelet responses in patients on aspirin","volume":"15","author":"Sambola","year":"2004","journal-title":"Platelets"},{"key":"10.1016\/j.thromres.2006.11.012_bib70","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/j.1365-2044.2005.04291.x","article-title":"Use of the platelet function analyser (PFA-100) to quantify the effect of low dose aspirin in patients with ischaemic heart disease","volume":"60","author":"Coakley","year":"2005","journal-title":"Anaesthesia"},{"key":"10.1016\/j.thromres.2006.11.012_bib71","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijcard.2004.03.069","article-title":"Prevalence of aspirin resistance measured by PFA-100","volume":"101","author":"Coma-Canella","year":"2005","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.thromres.2006.11.012_bib72","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1023\/A:1015231226086","article-title":"In vitro bleeding test with PFA-100-aspects of controlling individual acetylsalicylic acid induced platelet inhibition in patients with cardiovascular disease","volume":"12","author":"Peters","year":"2001","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.thromres.2006.11.012_bib73","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/01.mbc.0000187252.09759.ba","article-title":"Platelet hyper-function in acute coronary syndromes","volume":"16","author":"Harrison","year":"2005","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.thromres.2006.11.012_bib74","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/09537100400020567","article-title":"Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA","volume":"16","author":"McCabe","year":"2005","journal-title":"Platelets"},{"key":"10.1016\/j.thromres.2006.11.012_bib75","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1161\/01.STR.0000106763.46123.F6","article-title":"Antiplatelet effect of aspirin in patients with cerebrovascular disease","volume":"35","author":"Alberts","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2006.11.012_bib76","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1046\/j.1365-2141.2003.04727.x","article-title":"In vitro aspirin resistance detected by PFA-100 closure time: pivotal role of plasma von Willebrand factor","volume":"124","author":"Chakroun","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2006.11.012_bib77","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1161\/01.CIR.0000141575.92958.9C","article-title":"Platelet function predicts myocardial damage in patients with acute myocardial infarction","volume":"110","author":"Frossard","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2006.11.012_bib78","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0049-3848(02)00210-4","article-title":"Resistance to aspirin in vitro is associated with increased platelet sensitivity to adenosine diphosphate","volume":"107","author":"Macchi","year":"2002","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2006.11.012_bib79","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1161\/01.STR.0000162719.11058.bd","article-title":"Screening for aspirin responsiveness after transient ischemic attack and stroke: comparison of 2 point-of-care platelet function tests with optical aggregometry","volume":"36","author":"Harrison","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2006.11.012_bib80","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0002-9149(01)01631-9","article-title":"Profile and prevalence of aspirin resistance in patients with cardiovascular disease","volume":"88","author":"Gum","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.thromres.2006.11.012_bib81","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0735-1097(02)03014-0","article-title":"A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease","volume":"41","author":"Gum","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.thromres.2006.11.012_bib82","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/S0735-1097(03)00999-9","article-title":"Determination of the natural history of aspirin resistance among stable patients with cardiovascular disease","volume":"42","author":"Steinhubl","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.thromres.2006.11.012_bib83","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.jacc.2004.01.011","article-title":"Therapeutic failure or resistance to aspirin","volume":"43","author":"Jilma","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.thromres.2006.11.012_bib84","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0735-1097(02)03013-9","article-title":"Aspirin resistance: a new independent predictor of vascular events?","volume":"41","author":"Eikelboom","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.thromres.2006.11.012_bib85","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00415-003-0954-y","article-title":"Aspirin non-responder status in patients with recurrent cerebral ischemic attacks","volume":"250","author":"Grundmann","year":"2003","journal-title":"J Neurol"},{"key":"10.1016\/j.thromres.2006.11.012_bib86","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1161\/01.CIR.0000055317.72067.23","article-title":"Relation between platelet response to exercise and coronary angiographic findings in patients with effort angina","volume":"107","author":"Lanza","year":"2003","journal-title":"Circulation"},{"issue":"supplement 1","key":"10.1016\/j.thromres.2006.11.012_bib87","article-title":"Platelet hyperfunction and low response to aspirin predict re-events in patients with acute coronary syndromes during long term follow up","volume":"3","author":"Fuchs","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"supplement 1","key":"10.1016\/j.thromres.2006.11.012_bib88","article-title":"High shear platelet function is associated with major adverse events in patients with Stable cardiovascular disease (CVD) despite aspirin therapy","volume":"3","author":"Christie","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2006.11.012_bib89","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5507\/bp.2001.015","article-title":"Application of cationic propyl gallate as inducer of thrombocyte aggregation for evaluation of effectiveness ofantiaggregation therapy","volume":"145","author":"Stejskal","year":"2001","journal-title":"Biomed Pap Med Fac Palacky Univ Olomouc Czech Repub"},{"key":"10.1016\/j.thromres.2006.11.012_bib90","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00001721-200406000-00002","article-title":"Assessing aspirin responsiveness in subjects with multiple risk factors for vascular disease with a rapid platelet function analyzer","volume":"15","author":"Malinin","year":"2004","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.thromres.2006.11.012_bib91","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.amjcard.2003.08.072","article-title":"Incidence of aspirin nonresponsiveness using the Ultegra Rapid Platelet Function Assay-ASA","volume":"92","author":"Wang","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.thromres.2006.11.012_bib92","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.amjcard.2005.04.056","article-title":"Relation of aspirin resistance to coronary flow reserve in patients undergoing elective percutaneous coronary intervention","volume":"96","author":"Chen","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.thromres.2006.11.012_bib93","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.jacc.2003.12.034","article-title":"Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment","volume":"43","author":"Chen","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.thromres.2006.11.012_bib94","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.amjmed.2005.03.041","article-title":"Low-dose aspirin increases aspirin resistance in patients with coronary artery disease","volume":"118","author":"Lee","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.thromres.2006.11.012_bib95","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1161\/01.CIR.0000013777.21160.07","article-title":"Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events","volume":"105","author":"Eikelboom","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2006.11.012_bib96","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1146\/annurev.pharmtox.46.120604.141207","article-title":"Regulation of platelet functions by P2 receptors","volume":"46","author":"Gachet","year":"2005","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.thromres.2006.11.012_bib97","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2006.11.012_bib98","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","article-title":"Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study","volume":"358","author":"Mehta","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2006.11.012_bib99","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(04)16721-4","article-title":"Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial","volume":"364","author":"Diener","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2006.11.012_bib100","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1055\/s-2005-869523","article-title":"Clopidogrel and ticlopidine: P2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis","volume":"31","author":"Savi","year":"2005","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.thromres.2006.11.012_bib101","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jacc.2004.09.067","article-title":"Variability in platelet responsiveness to clopidogrel among 544 individuals","volume":"45","author":"Serebruany","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.thromres.2006.11.012_bib102","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.jacc.2005.01.034","article-title":"Resistance to clopidogrel: a review of the evidence","volume":"45","author":"Nguyen","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.thromres.2006.11.012_bib103","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1161\/01.CIR.0000072771.11429.83","article-title":"Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity","volume":"107","author":"Gurbel","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2006.11.012_bib104","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1046\/j.1365-2796.2002.01027.x","article-title":"Individual variations of platelet inhibition after loading doses of clopidogrel","volume":"252","author":"Jaremo","year":"2002","journal-title":"J Intern Med"},{"key":"10.1016\/j.thromres.2006.11.012_bib105","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1161\/01.CIR.0000112378.09325.F9","article-title":"Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance","volume":"109","author":"Lau","year":"2004","journal-title":"Circulation"},{"issue":"supplement 1","key":"10.1016\/j.thromres.2006.11.012_bib106","article-title":"Pre-existent variability in platelet response to ADP accounts for clopidogrel resistance","volume":"3","author":"Michelson","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2006.11.012_bib107","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1373\/clinchem.2004.047050","article-title":"Monitoring of clopidogrel action: comparison of methods","volume":"51","author":"Geiger","year":"2005","journal-title":"Clin Chem"},{"key":"10.1016\/j.thromres.2006.11.012_bib108","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.amjcard.2003.10.042","article-title":"Frequency of nonresponse antiplatelet activity of clopidogrel during pretreatment for cardiac catheterization","volume":"93","author":"Mobley","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.thromres.2006.11.012_bib109","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.jacc.2005.01.030","article-title":"The relation of dosing to clopidogrel responsiveness and the incidence of high post-treatment platelet aggregation in patients undergoing coronary stenting","volume":"45","author":"Gurbel","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.thromres.2006.11.012_bib110","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/heart.85.1.92","article-title":"Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement","volume":"85","author":"Muller","year":"2001","journal-title":"Heart"},{"key":"10.1016\/j.thromres.2006.11.012_bib111","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1161\/01.CIR.0000157138.02645.11","article-title":"Clopidogrel loading with eptifibatide to arrest the reactivity of platelets: results of the Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets (CLEAR PLATELETS) study","volume":"111","author":"Gurbel","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2006.11.012_bib112","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1538-7836.2004.01063.x","article-title":"Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases","volume":"3","author":"Aleil","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2006.11.012_bib113","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1161\/01.CIR.0000130846.46168.03","article-title":"Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction","volume":"109","author":"Matetzky","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2006.11.012_bib114","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0143-4160(03)00170-2","article-title":"Inhibition of ADP-induced intracellular Ca2+responses and platelet aggregation by the P2Y12 receptor antagonists AR-C69931MX and clopidogrel is enhanced by prostaglandin E1","volume":"35","author":"Fox","year":"2004","journal-title":"Cell Calcium"},{"key":"10.1016\/j.thromres.2006.11.012_bib115","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1016\/0006-2952(90)90587-B","article-title":"The thienopyridine ticlopidine selectively prevents the inhibitory effects of ADP but not of adrenaline on cAMP levels raised by stimulation of the adenylate cyclase of human platelets by PGE1","volume":"40","author":"Gachet","year":"1990","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.thromres.2006.11.012_bib116","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/ccd.10497","article-title":"Resistance to thienopyridines: clinical detection of coronary stent thrombosis by monitoring of vasodilator-stimulated phosphoprotein phosphorylation","volume":"59","author":"Barragan","year":"2003","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.thromres.2006.11.012_bib117","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1515\/CCLM.2004.006","article-title":"Limited usefulness of the PFA-100 for the monitoring of ADP receptor antagonists \u2014 in vitro experience","volume":"42","author":"Golanski","year":"2004","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.thromres.2006.11.012_bib118","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/153857440303700206","article-title":"Monitoring aspirin 100\u00a0mg and clopidogrel 75\u00a0mg therapy with the PFA-100 device in patients with peripheral arterial disease","volume":"37","author":"Mueller","year":"2003","journal-title":"Vasc Endovascular Surg"},{"key":"10.1016\/j.thromres.2006.11.012_bib119","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1080\/0953710021000057866","article-title":"Monitoring of antiplatelet therapy with the PFA-100 in peripheral angioplasty patients","volume":"13","author":"Ziegler","year":"2002","journal-title":"Platelets"},{"key":"10.1016\/j.thromres.2006.11.012_bib120","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1111\/j.1538-7836.2006.01950.x","article-title":"Can the PFA-100 be modified to detect P2Y12 inhibition?","volume":"4","author":"Pidcock","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2006.11.012_bib121","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1111\/j.1538-7836.2004.01046.x","article-title":"Time lag in platelet function inhibition by clopidogrel in stroke patients as measured by PFA-100","volume":"2","author":"Raman","year":"2004","journal-title":"J Thromb Haemost"},{"issue":"4","key":"10.1016\/j.thromres.2006.11.012_bib122","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1161\/01.STR.0000064326.65899.AC","article-title":"Synergistic antiplatelet effects of Clopidogrel and aspirin detected with the PFA-100 in stroke patients","volume":"34","author":"Jilma","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2006.11.012_bib123","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/j.jacc.2005.07.056","article-title":"Clopidogrel effect on platelet reactivity in patients with stent thrombosis: results of the CREST Study","volume":"46","author":"Gurbel","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.thromres.2006.11.012_bib124","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1055\/s-0037-1613462","article-title":"Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement","volume":"89","author":"Muller","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2006.11.012_bib125","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1161\/01.CIR.80.6.1766","article-title":"Abolition of in vivo platelet thrombus formation in primates with monoclonal antibodies to the platelet GPIIb\/IIIa receptor. Correlation with bleeding time, platelet aggregation, and blockade of GPIIb\/IIIa receptors","volume":"80","author":"Coller","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2006.11.012_bib126","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1161\/01.CIR.77.3.670","article-title":"Rapid and sustained coronary artery recanalization with combined bolus injection of recombinant tissue-type plasminogen activator and monoclonal antiplatelet GPIIb\/IIIa antibody in a canine preparation","volume":"77","author":"Gold","year":"1988","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2006.11.012_bib127","first-page":"270","article-title":"Monitoring of platelet function in the setting of GPIIa\/IIIb inhibitor therapy","volume":"1","author":"Thompson","year":"1999","journal-title":"Curr Interv Cardiol Rep"},{"key":"10.1016\/j.thromres.2006.11.012_bib128","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1067\/mhj.2002.121734","article-title":"The Ultegra rapid platelet-function assay: comparison to standard platelet function assays in patients undergoing percutaneous coronary intervention with abciximab therapy","volume":"143","author":"Wheeler","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.thromres.2006.11.012_bib129","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ccd.1096","article-title":"A comparative study of light transmission aggregometry and automated bedside platelet function assays in patients undergoing percutaneous coronary intervention and receiving abciximab, eptifibatide, or tirofiban","volume":"52","author":"Simon","year":"2001","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.thromres.2006.11.012_bib130","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1161\/01.CIR.103.21.2572","article-title":"Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention: results of the GOLD (AU \u2014 Assessing Ultegra) multicenter study","volume":"103","author":"Steinhubl","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2006.11.012_bib131","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1055\/s-0037-1613859","article-title":"Use of the PFA-100 apparatus to assess platelet function in patients undergoing PTCA during and after infusion of c7E3 Fab in the presence of other antiplatelet agents","volume":"83","author":"Hezard","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2006.11.012_bib132","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1067\/mhj.2001.112489","article-title":"Rapid assessment of glycoprotein IIb\/IIIa blockade with the platelet function analyzer (PFA-100) during percutaneous coronary intervention","volume":"141","author":"Madan","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.thromres.2006.11.012_bib133","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1067\/mhj.2002.123581","article-title":"Determination of platelet aggregation inhibition during percutaneous coronary intervention with the platelet function analyzer PFA-100","volume":"144","author":"Madan","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.thromres.2006.11.012_bib134","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/CIRCULATIONAHA.105.170815","volume":"113","author":"Smith","year":"2006","journal-title":"Circulation"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384806005007?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384806005007?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T16:07:41Z","timestamp":1587312461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384806005007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":134,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0049384806005007"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2006.11.012","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}